How is neuroplasticity measured?
Neuroplasticity is assessed through a combination of clinical rating scales, blood and imaging biomarkers, and behavioural tasks. This page outlines the methods used in registered studies and preclinical models, with a c
How is neuroplasticity measured?
Neuroplasticity is not a single analyte; it is a set of structural and functional changes in the nervous system. In research settings, it is measured indirectly through clinical scales, blood-based biomarkers, neuroimaging, and behavioural performance. The formal term for the property being assessed is neuroplasticity, sometimes called neural plasticity or brain plasticity. It is a physiological process, not a molecule, so it has no sequence, formula, or molecular weight. Instead, studies measure proxies: changes in cognitive scores, levels of neurotrophic or inflammatory proteins, and task-based recovery metrics.
Across the evidence reviewed here, the work centres on several pathways and receptor families, including the gut-brain axis, neurotrophic signalling, and neuroimmune modulation. The sections below summarise how specific studies operationalise the measurement of neuroplasticity.
Research Studies
Incretin therapy and exercise in type 2 diabetes: measuring brain health
A registered clinical trial is examining changes in brain and physical health in adults with type 2 diabetes who are initiating incretin-mimetic therapy [1]. Participants are randomised to receive incretin-mimetic therapy alone or incretin-mimetic therapy plus a structured exercise programme for 24 weeks. Brain health is assessed through cognitive performance, mental health, and brain-mediated appetite measures. This study uses cognitive and behavioural tests as indirect indices of neuroplasticity in a human population with type 2 diabetes.
Intermittent theta burst stimulation in treatment-resistant depression: biomarkers of response
A single-centre, prospective study is investigating the effects of intermittent theta burst stimulation (iTBS) on clinical symptoms, executive functions, and peripheral inflammatory and neuroprotective biomarkers in patients with treatment-resistant depression [2]. iTBS is a non-invasive neuromodulation technique targeting the left dorsolateral prefrontal cortex. The study aims to link changes in peripheral biomarkers to treatment response, providing a measurable correlate of neuroplasticity in a clinical population.
Gut Proteobacteria glycine metabolism and neuroplasticity in mice
In mice, cocaine exposure alters the gut microbiome, increasing the abundance of Proteobacteria [3]. This microbial shift leads to a depletion in host glycine levels, altering cocaine-induced transcriptional changes in the nucleus accumbens and facilitating behavioural sensitisation. The study demonstrates a mechanistic link between gut bacterial metabolism and neuroplasticity in a preclinical model.
Cerebrolysin as an adjunct to speech-language therapy in post-stroke Wernicke's aphasia: a case report
A case report describes a 38-year-old female lawyer who developed acute Wernicke's aphasia and right-sided hemiparesis following an ischemic stroke [4]. Early multidisciplinary rehabilitation combined with a 10-day course of Cerebrolysin was associated with recovery. The report suggests that Cerebrolysin may enhance recovery through neuroprotection and neuroplasticity, though as a single case it provides low-level evidence.
Rejuvenation of corticospinal neurons and rehabilitation-associated sprouting in mice
In a mouse model of photothrombotic ischemic stroke, ectopic expression of a cocktail of transcriptional factors (Oct4, Sox2, and Klf4, referred to as OSKTFs) reset developmental decline of epigenetic signatures in adult corticospinal neurons [5]. Corticospinal expression of OSKTFs had moderate effects on promoting collateral sprouting of corticospinal tract axons and recovery of skilled motor function. When combined with task-dependent rehabilitation, the effects were enhanced. This study measures neuroplasticity through axon sprouting and functional recovery in mice.
Cytokines, neuroplasticity modulators, and biomarkers in spinal canal stenosis and endoscopic decompression
A clinical study is investigating the pathophysiological mechanisms of lumbar spinal stenosis, focusing on histological changes in hypertrophied ligamentum flavum and the role of cytokines and neuroplasticity modulators [6]. The study aims to identify biomarkers associated with endoscopic decompression outcomes. This work measures neuroplasticity-related markers in a human musculoskeletal disorder.
Cerebrolysin and language ability in non-fluent aphasia after stroke: a randomised controlled trial
A randomised, placebo-controlled, double-blinded study is measuring changes in language ability after adding Cerebrolysin to standard speech therapy in patients with non-fluent aphasia post-stroke [7]. The primary outcome is the PK-WAB score, a validated language assessment. The study compares an experimental group receiving Cerebrolysin plus speech therapy with a control group receiving speech therapy alone. Language recovery is used as an indirect measure of neuroplasticity in this population.
Psilocybin and psilocybin-assisted cognitive behavioural therapy in major depressive disorder
A randomised controlled trial is evaluating the effectiveness of psilocybin and psilocybin-assisted cognitive behavioural therapy (CBT) in the management of major depressive disorder [8]. The study compares psilocybin-only therapy, CBT, and psilocybin-assisted CBT on depression symptoms, neurochemical markers, inflammatory markers, and neuroplasticity. Participants continue their routine depression medications and are assessed for changes in depression scores, biochemical markers, and brain activity patterns. This trial uses a combination of clinical, biochemical, and neurophysiological measures to assess neuroplasticity in individuals with MDD.
Comparison of neuroplasticity measures across studies
| Study | Population/Model | Neuroplasticity Measure(s) |
|---|---|---|
| Incretin therapy and exercise [1] | Adults with type 2 diabetes | Cognitive performance, mental health, brain-mediated appetite |
| iTBS in treatment-resistant depression [2] | Patients with treatment-resistant depression | Executive functions, peripheral inflammatory and neuroprotective biomarkers |
| Gut Proteobacteria in mice [3] | Mice | Transcriptional changes in nucleus accumbens, behavioural sensitisation |
| Cerebrolysin case report [4] | Human case (post-stroke Wernicke's aphasia) | Clinical recovery, language function |
| OSKTFs in mice [5] | Mice (photothrombotic stroke) | Corticospinal tract axon sprouting, skilled motor recovery |
| Spinal canal stenosis study [6] | Patients with lumbar spinal stenosis | Cytokines, neuroplasticity modulators, biomarkers |
| Cerebrolysin in non-fluent aphasia [7] | Patients with post-stroke non-fluent aphasia | PK-WAB language scores |
| Psilocybin in MDD [8] | Patients with major depressive disorder | Depression scores, neurochemical markers, inflammatory markers, brain activity |
If you are reading this for personal health reasons
The materials and compounds discussed on this page are sold for laboratory research only. We do not provide dosing, medical guidance, or treatment advice. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Incretin Therapy and Exercise in Type 2 Diabetes
- [2] Relationship of Peripheral Inflammatory and Neuroprotective Biomarkers With Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression
- [3] Gut Proteobacteria glycine metabolism regulates neuroplasticity, motivation, and reinstatement of cocaine self-administration in mice
- [4] Cerebrolysin as an adjunct to speech-language therapy in post-stroke Wernicke's aphasia: a case report
- [5] Rejuvenation of corticospinal neurons enhances rehabilitation-associated corticospinal tract axon sprouting and functional recovery post photothrombotic ischemic stroke in mice
- [6] Cytokines, Neuroplasticity Modulators, and Biomarkers in Spinal Canal Stenosis and Endoscopic Decompression
- [7] Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study
- [8] Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers